http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-0402477-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_44e0905262f429c7590b40df8448c0c5 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517 |
| filingDate | 2002-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72cdc8e71be905b25d0ec0197a00b4c2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_93d16a4047ea0da953a1bd0434bf66db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebeea9974d8d10688d5281224831bbac http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec16794f8cfb60cbf1056ebdf512ead0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_844843da58b3ee128ab71f106139f696 |
| publicationDate | 2005-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-0402477-A2 |
| titleOfInvention | Piperidine-2,6-dione substituted at the 3-position by heterocyclic group |
| abstract | The present invention relates to piperidine-2,6-deones of formula (I) substituted at the 3-position with a heterocyclic group; relates to the preparation and use as a medicament of these compounds. The therapeutic agents of the invention are particularly useful in the treatment and / or prevention of immune modulators and inflammatory and autoimmune diseases, as well as haematological-oncological diseases. In the formula, R 1 and R 2 may be the same or different hydrogen, bromine, chlorine; fluorine, trifluoromethyl, hydroxy, nitro, amino, dimethylamino, (C 1 -C 3) alkyl, (C 1 -C 3) alkoxy or phenyl; or R1 and R2 together form a fused benzene ring; wherein the rings may be optionally substituted with R 1 and / or R 2; wherein R1 and R2 are as defined above; R3 is hydrogen, methyl or, when the C-N bond is a single bond, hydroxy, (C1-C3) -alkoxy or [O (CO) -1-C3-alkyl]; or together with a carbon atom form a carbonyl group; R 4 is hydrogen, fluoro, trifluoromethyl or C 1 -C 3 alkyl, R 5 is hydrogen, hydroxymethyl or CH 2 -NR 6 R 7 (wherein R 6 and R 7 may be the same or different and are linear or branched C 1 -C 6 alkyl, or R 6 and R 7 together with the nitrogen atom to which they are attached form pyrrolidine, piperidine, hexarethyleneimine or morpholine ring); n is 0 or 1 and m is 0, 1 or 2. Oh |
| priorityDate | 2001-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 265.